본문 바로가기 주메뉴 바로가기
  • HOME
  • Public Relations
  • GC Cell News

GC Cell News

Green Cross Cell Selected as ‘2017 KICOX Global Leading Company’
2017-10-16

Green Cross Cell has been selected as ‘2017 KICOX Global Leading Company’, an honor which is bestowed by the Korea Industrial Complex Corporation (KICOX).

Since 2014 and in commemoration of 50th anniversary of Industrial Complex, KICOX has been operating this business in order to select 300 creative and innovative companies which represent the Industrial Complex and have global competitiveness to Hall of Fame. KICOX intensively fosters and provides support services for these promising entities.

Thirty-three companies have been chosen this year, and Green Cross Cell could become one of the 33 companies thanks to its GMP facility as well as its high tech immune cell therapy ‘immunecell-LC’ which has potential in terms of entering the global market and in terms of future growth.

Companies selected as global leading company(s) are each provided a customized growth support program developed from comprehensive enterprise growth support platform businesses by KICOX. In particular, many benefits which could directly facilitate a companys’ entrance into the global market such as financial support from each financial institutions, interest rate benefit in Co-growth cooperation fund, mentoring program on export from KOTRA, FTA, global marketing support, business strengthening competitiveness of industry cluster, and support for global technology exchange are offered.

Selected as 2017 KICOX global leading company, Green Cross Cell highly anticipates that this selection could substantially assist the company in entering the global market, which is our task.

Green Cross Cell will exert our very best effort in R&D, and operating the business with the goal and intention of becoming a Global Leader in cell therapy market.

2017 KICOX 글로벌 선도기업

※ KICOX(Korea Industrial Complex Corporation, 한국산업단지공단)

Next
GC Cell Entered into an Agreement of Cooperation to go to Russia
Previous
Green Cross Cell, Maryland agree to expand the cooperation between the biohealth and life science sectors